149 research outputs found
Isolation of a novel bio-peptide from walnut residual protein inducing apoptosis and autophagy on cancer cells
Tip-induced bond weakening, tilting, and hopping of a single CO molecule on Cu(100)
The interaction between a probing tip and an adsorbed molecule can significantly impact the molecular chemical structure and even induce its motion on the surface. In this study, the tip-induced bond weakening, tilting, and hopping processes of a single molecule were investigated by sub-nanometre resolved tip-enhanced Raman spectroscopy (TERS). We used single carbon monoxide (CO) molecules adsorbed on the Cu (100) surface as a model system for the investigation. The vibrational frequency of the C−O stretching mode is always redshifted as the tip approaches, revealing the weakening of the C−O bond owing to tip−molecule interactions. Further analyses of both the vibrational Stark effect and TERS imaging patterns suggest a delicate tilting phenomenon of the adsorbed CO molecule on Cu(100), which eventually leads to lateral hopping of the molecule. While a tilting orientation is found toward the hollow site along the [110] direction of the Cu(100) surface, the hopping event is more likely to proceed via the bridge site to the nearest Cu neighbour along the [100] or [010] direction. Our results provide deep insights into the microscopic mechanisms of tip−molecule interactions and tip-induced molecular motions on surfaces at the single-bond level
GFP Labeling and Hepatic Differentiation Potential of Human Placenta-Derived Mesenchymal Stem Cells
Deficiency of Smad7 Enhances Cardiac Remodeling Induced by Angiotensin II Infusion in a Mouse Model of Hypertension
Smad7 has been shown to negatively regulate fibrosis and inflammation, but its role in angiotensin II (Ang II)-induced hypertensive cardiac remodeling remains unknown. Therefore, the present study investigated the role of Smad7 in hypertensive cardiopathy induced by angiotensin II infusion. Hypertensive cardiac disease was induced in Smad7 gene knockout (KO) and wild-type (WT) mice by subcutaneous infusion of Ang II (1.46 mg/kg/day) for 28 days. Although equal levels of high blood pressure were developed in both Smad7 KO and WT mice, Smad7 KO mice developed more severe cardiac injury as demonstrated by impairing cardiac function including a significant increase in left ventricular (LV) mass (P<0.01),reduction of LV ejection fraction(P<0.001) and fractional shortening(P<0.001). Real-time PCR, Western blot and immunohistochemistry detected that deletion of Smad7 significantly enhanced Ang II-induced cardiac fibrosis and inflammation, including upregulation of collagen I, α-SMA, interleukin-1β, TNF-α, and infiltration of CD3+ T cells and F4/80+ macrophages. Further studies revealed that enhanced activation of the Sp1-TGFβ/Smad3-NF-κB pathways and downregulation of miR-29 were mechanisms though which deletion of Smad7 promoted Ang II-mediated cardiac remodeling. In conclusions, Smad7 plays a protective role in AngII-mediated cardiac remodeling via mechanisms involving the Sp1-TGF-β/Smad3-NF.κB-miR-29 regulatory network. © 2013 Wei et al.published_or_final_versio
EFFECTS OF SALVIA MILTIORRHIZAE ON THE KIDNEY OF RATS WITH SEVERE ACUTE PANCREATITIS AND OBSTRUTIVE JAUNDICE
Background: Severe acute pancreatitis (SAP) and obstructive jaundice (OJ) are frequent recurring diseases that bring
about huge threat to human health. Some reports have demonstrated that Salviae miltiorrhizae can protect multiple
organs of SAP and OJ model animals or patients, but their related mechanisms were not clear. In this study, we
observed the effects of Salvia miltiorrhizae injection on apoptosis and NF-κB expression in kidney and explored the
protective effect and mechanism of Salvia miltiorrhizae on the kidney of SAP or OJ rats. The results obtained will
provide a theoretical basis for clinical application of Salvia miltiorrhizae.
Material and Methods: A total of 288 rats were used for SAP - and OJ-associated experiments. The mortality rates of
rats, the contents of serum BUN and CREA, the expression levels of Bax, NF-κB proteins and the apoptosis index were
observed, respectively.
Results: The pathological changes in the kidney of SAP or OJ rats in treated group were mitigated to varying degrees.
At 6 and 12 hours after operation in SAP rats or on 21 and 28 days after operation in OJ rats, the contents of serum
CREA in treated group were significantly lower than those in model control group; At 3 and 6 hours after operation,
the staining intensity of Bax protein of kidney in treated group was significantly lower than that in model control group;
on 14 days after operation, the apoptosis index in the kidney of OJ rats in treated group was significantly lower than
that in model control group.
Conclusion: Salvia miltiorrhizae can exert protective effects on the kidney of SAP and OJ rats
Association and interactions between mixed exposure to trace elements and the prevalence of kidney stones: a study of NHANES 2017–2018
BackgroundThe association between exposure to trace elements mixture and the prevalence of kidney stones and the interactions between elements are unclear. The aim of this study was to explore the association between exposure to trace elements mixture and the prevalence of kidney stones and the interactions between the elements.MethodsA total of 1,244 participants (139 kidney stone formers and 1,105 non-stone former participants) in NHANES 2017–2018 were included. The exposure to trace elements was evaluated by measuring their concentration in urine samples. Three methods, Logistic regression, quantile-based g computation (qgcomp), and Bayesian kernel machine regression (BKMR), were used for analysis.ResultsAccording to the results from qgcomp and BKMR, a negative association was found between exposure to the 13 trace elements and the prevalence of kidney stones [OR = 0.50 (0.32, 0.78)]. Subgroup analysis revealed that Co, As, and iodine in the whole population, Co, As, and Ni in males, and Cs, iodine, and Sb in females, were most strongly associated with kidney stones. Kidney stone was found to be positively correlated with Co and negatively correlated with the other elements. Besides, there were significant interactions between Ni and Pb in the whole population, Co and iodine in males, and Pb and iodine in females.ConclusionThere was a negative association between exposure to the mixture of 13 trace elements and the prevalence of kidney stones
Isolation of a novel bio-peptide from walnut residual protein inducing apoptosis and autophagy on cancer cells
Household, community, sub-national and country-level predictors of primary cooking fuel switching in nine countries from the PURE study
Introduction. Switchingfrom polluting (e.g. wood, crop waste, coal)to clean (e.g. gas, electricity) cooking
fuels can reduce household air pollution exposures and climate-forcing emissions.While studies have
evaluated specific interventions and assessed fuel-switching in repeated cross-sectional surveys, the role
of different multilevel factors in household fuel switching, outside of interventions and across diverse
community settings, is not well understood. Methods.We examined longitudinal survey data from
24 172 households in 177 rural communities across nine countries within the Prospective Urban and
Rural Epidemiology study.We assessed household-level primary cooking fuel switching during a
median of 10 years offollow up (∼2005–2015).We used hierarchical logistic regression models to
examine the relative importance of household, community, sub-national and national-level factors
contributing to primary fuel switching. Results. One-half of study households(12 369)reported
changing their primary cookingfuels between baseline andfollow up surveys. Of these, 61% (7582)
switchedfrom polluting (wood, dung, agricultural waste, charcoal, coal, kerosene)to clean (gas,
electricity)fuels, 26% (3109)switched between different polluting fuels, 10% (1164)switched from clean
to polluting fuels and 3% (522)switched between different clean fuels
Household, community, sub-national and country-level predictors of primary cooking fuel switching in nine countries from the PURE study
Recommended from our members
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation
- …